Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls

admin by admin
November 18, 2024
in Stock
0
Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Investing.com — US stock futures traded in a mixed fashion Monday, with traders awaiting more corporate earnings as well as speeches from a number of Fed officials.

Here are some of the biggest premarket US stock movers today:

  • Tesla (NASDAQ:TSLA) stock surged 5.9% following reports from Bloomberg that the incoming Trump administration will establish a federal framework for fully self-driving vehicles and make it a top priority for the Department of Transportation.

  • Nvidia (NASDAQ:NVDA) stock fell 3.4% amid doubts over the strength of sales of its new Blackwell chips, ahead of the chipmaker’s quarterly earnings on Wednesday.

  • Spirit Airlines (NYSE:SAVE) stock rose 2.8% after the budget carrier filed for bankruptcy protection after years of mounting losses, stating that it has reached a prearranged deal with its bondholders to help it through the bankruptcy, which it expects to exit in the first quarter of next year.

  • Ford (NYSE:F) stock rose 0.3% despite the US auto safety regulator stating it had initiated a recall query into about 112,567 of the auto giant’s SUVs over an issue with seat belt retractors.

  • CVS Health (NYSE:CVS) stock rose 1.9% after the pharmacy chain said it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund’s chief executive Larry Robbins.

  • Super Micro Computer (NASDAQ:SMCI) stock rose over 10% as investors awaited a planned filing that would allow the server maker to avoid being delisted

  • Astera Labs (NASDAQ:ALAB) stock rose 3% after Citi initiated coverage of the semiconductor stock with a ‘buy’ rating, saying the shares provide artificial intelligence investors with a unique opportunity.

  • Syndax Pharmaceuticals (NASDAQ:SNDX) stock rose 6% after the FDA approved its Revuforj drug for the treatment of certain leukemia patients.

This post appeared first on investing.com

Previous Post

Brazil sees 3.3% GDP growth this year and 2.5% next year

Next Post

CVS adds four new board members in deal with Glenview Capital

admin

admin

Next Post
CVS adds four new board members in deal with Glenview Capital

CVS adds four new board members in deal with Glenview Capital

Trending News

Paul Marchant resigns as Primark boss after admitting an “error of judgment”: what’s next for the retail giant?

Paul Marchant resigns as Primark boss after admitting an “error of judgment”: what’s next for the retail giant?

March 31, 2025
Trade war poses greater threat than COVID for emerging market central banks: IMF

Trade war poses greater threat than COVID for emerging market central banks: IMF

June 7, 2025
Explained: what is going on in Turkey?

Explained: what is going on in Turkey?

March 24, 2025
Subscribe to Insightful Word


    Recent News

    Analysts life price target for Netflix after strong Q2 performance

    Analysts life price target for Netflix after strong Q2 performance

    July 18, 2025
    Meta declines to sign EU’s AI pact: what happens next?

    Meta declines to sign EU’s AI pact: what happens next?

    July 18, 2025
    Will the VOO ETF crash by 10% as a top Morgan Stanley analyst predicts?

    Will the VOO ETF crash by 10% as a top Morgan Stanley analyst predicts?

    July 18, 2025
    US stocks open in the green: S&P 500, Nasdaq hit fresh record highs

    US stocks open in the green: S&P 500, Nasdaq hit fresh record highs

    July 18, 2025

    Recent News

    Analysts life price target for Netflix after strong Q2 performance

    Analysts life price target for Netflix after strong Q2 performance

    July 18, 2025
    Meta declines to sign EU’s AI pact: what happens next?

    Meta declines to sign EU’s AI pact: what happens next?

    July 18, 2025

    Latest News

    • Analysts life price target for Netflix after strong Q2 performance
    • Meta declines to sign EU’s AI pact: what happens next?
    • Will the VOO ETF crash by 10% as a top Morgan Stanley analyst predicts?

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.